January 29, 2026
A clear guide to what genetic tests are used for, in which situations they are preferred, and how their results are interpreted.
December 16, 2025
Onkogenoks is the brand of Genoks Genetic Diseases Evaluation Center focused on cancer genetics and precision oncology solutions.
December 16, 2025
The exome refers to all protein-coding regions of the human genome. Although it constitutes only **1–2% of the genome**, more than 85% of known genetic diseases are located within exons. For this reason, exome analysis forms the foundation of modern diagnostic genetic testing.
December 16, 2025
The exome consists of all protein-coding regions, which make up only 1–2% of the genome. Because the vast majority of genetic diseases originate in these regions, exome analysis has become one of the most critical tools in modern diagnostic genetic testing.
December 16, 2025
RapidNIPT is a high-accuracy NIPT that screens for 90+ genetic conditions, including Down syndrome, using cfDNA. It is completely risk-free for both the mother and the baby.
December 16, 2025
RapidNIPT screens 90+ genetic disorders including Down syndrome from cfDNA. It is risk-free for both mother and baby and offers a high-accuracy NIPT test.
November 14, 2025
Onkogenoks is the brand of Genoks Genetic Diseases Evaluation Center focused on cancer genetics and precision oncology solutions.
November 14, 2025
The Carrier Screening Test evaluates carrier status for many genetic diseases that are hereditary and mostly autosomal recessive.
November 14, 2025
RapidNIPT screens for over 90 genetic conditions, including Down syndrome, using cfDNA analysis. It is a non-invasive test that poses no risk to either the mother or the baby and offers a high level of accuracy.